Article
Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.
Hepatology (Baltimore, Md.) - 1 Nov 2010
Brenndörfer Erwin Daniel, Weiland Malin, Frelin Lars, Derk Emma, Ahlén Gustaf, Jiao Jian, Bode Johannes Georg, Sällberg Matti
Abstract excerpt
UNLABELLED: Tumor necrosis factor α (TNFα) has been implicated in a variety of inflammatory diseases, and anti-TNFα has been shown to improve therapy when added to standard of care in chronic hepatitis C virus (HCV) infection. In addition, patients with chronic HCV have increased serum levels of TNFα and the macrophage-attracting chemokine (C-C motif) ligand 2 (CCL2). A mouse model of chronic HCV with hepatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
